PLUS PHARMACIES AS

Closed at January 4th, 2025, Lack of mandatory auditor

Liquidation estate:

Eie aksjer i andre selskaper og sammenslutninger, samt andre aktiviteter i sammenheng med dette. Drive konsulentvirksomhet og rådgivning innen helse og aktivitet.

Eie aksjer i andre selskaper og sammenslutninger, samt andre aktiviteter i sammenheng med dette samt Konsulentvirksomhet og rådgivning innen helse og aktivitet.

Keywords

environmental health protectioninformation servicecompanies' health servicethe hse servicemental health work

Organization

CEO: MA
Mari-Mette Aasen1970
Chairman of the board: MA
Mari-Mette Aasen1970
Operation time: 10 years; - Nov 23, 2015 to Jan 4, 2025
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 100; 1 share class
Total number of shareholders: 4; persons
Belongs to group of

Financials

Annual total result 2022: 36,959; NOK
Total equity 2022: -3,359,922; NOK

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
MA Mari-Mette Aasen 1970	Managing Director/CEO	70 % directly

Board

Name	Role	Shares
MA Mari-Mette Aasen 1970	Chairman	70 % directly
TR Tom Remman 1970	Board Member	10 % directly

Others

Name	Role	Shares
R REVISJONSFIRMAET HOTVEDT & CO AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
MA Mari-Mette Aasen 1970	Managing Director/CEO, Chairman	70 % directly
TR Tom Remman 1970	Board Member	10 % directly
MR Marius Remman 1996	-	10 % directly
MR Maren Remman 1999	-	10 % directly

Last update: Dec 4, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
MA Mari-Mette Aasen 1970	Ordinary shares	70	70 %
MR Maren Remman 1999	Ordinary shares	10	10 %
MR Marius Remman 1996	Ordinary shares	10	10 %
TR Tom Remman 1970	Ordinary shares	10	10 %

Shares owned by the PLUS PHARMACIES AS

Name	Share class	Total number of shares	Share
G GEILO APOTEK AS Closed	Ordinary shares	100	100 %
S SEMSBYEN APOTEK AS Closed	Ordinary shares	100	100 %

Last update: Apr 4, 2024

Group structure

PLUS PHARMACIES AS
Total operating income 2022: NOK 0
Operating profit 2022: NOK -20,902
Employees: 0

Financials

in NOK

Summary

Year	2022	2021
Total operating income	0	0
Annual Total Result	36,959	608,766
Total assets	1,319,885	1,590,078
Total liabilities	4,679,807	4,986,959
Total equity	-3,359,922	-3,396,881

P&L

Year	2022	2021
Total operating income	0	0
Total operating costs	20,902	60,249
Operating result	-20,902	-60,249
Financial income/costs	57,861	669,015
Profit before tax	36,959	608,766
Total tax & extraordinary income/cost	0	0
Annual Total Result	36,959	608,766

Balance overview

Year	2022	2021
Total fixed assets	1,130,000	1,265,000
Total current assets	189,885	325,078
Total assets	1,319,885	1,590,078
Short term debt	2,000,249	961,144
Long term debt	2,679,558	4,025,815
Total liabilities	4,679,807	4,986,959
Contributed capital	30,000	30,000
Retained earnings	-3,389,922	-3,426,881
Total equity	-3,359,922	-3,396,881
Total equity and liabilities	1,319,885	1,590,078

Classification

21st company classification

BETA

Small company

PLUS PHARMACIES AS916 278 667